Literature DB >> 22226813

Melanoma in situ in a private practice setting 2005 through 2009: location, lesion size, lack of concern.

Sherea M Stricklin1, William V Stoecker, Joseph M Malters, Rhett Drugge, Margaret Oliviero, Harold S Rabinovitz, Lindall A Perry.   

Abstract

BACKGROUND: Studies have shown that the incidence of melanoma in situ (MIS) is increasing significantly.
OBJECTIVE: This study analyzes selected clinical and demographic characteristics of MIS cases observed in private dermatology practices in the United States.
METHODS: This study collected 257 MIS cases from 4 private dermatology practices in the United States from January 2005 through December 2009, recording age, gender, anatomic location, lesion size, patient-reported change in lesion, and concern about lesion. Case totals for invasive melanoma during the same period were recorded.
RESULTS: The data collected showed a higher incidence of MIS in sun-exposed areas of older patients, especially men. The median age of patients at the time of MIS detection was 69 years. The most common site for MIS was the head-neck region. The number of MIS cases collected exceeded the number of invasive malignant melanoma cases during the study period, with an observed ratio of 1.35:1. LIMITATIONS: For 136 patients, data were collected retrospectively for lesion size, location, gender, and age. For these patients, patient-reported change in lesion and concern about lesion were not collected. Patients often did not consent to a full body examination, therefore, it is possible that MIS lesions may have been missed in double-clothed areas.
CONCLUSION: Careful attention to pigmented lesions, even lesions less than 4 mm, on sun-exposed areas, including scalp, trunk, and feet, will facilitate earlier diagnosis of MIS. As only 30.4% of male patients and 50% of female patients had concern about these lesions, it still falls to the dermatologist to discover MIS.
Copyright © 2011 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22226813      PMCID: PMC3419337          DOI: 10.1016/j.jaad.2011.11.949

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

Review 1.  Lentigo maligna.

Authors:  Gert J Smalberger; Daniel Mark Siegel; Amor Khachemoune
Journal:  Dermatol Ther       Date:  2008 Nov-Dec       Impact factor: 2.851

2.  Accuracy in melanoma detection: a 10-year multicenter survey.

Authors:  Giuseppe Argenziano; Lorenzo Cerroni; Iris Zalaudek; Stefania Staibano; Rainer Hofmann-Wellenhof; Nicola Arpaia; Renato Marchiori Bakos; Brigitte Balme; Jadran Bandic; Roberto Bandelloni; Alexandra M G Brunasso; Horacio Cabo; David A Calcara; Blanca Carlos-Ortega; Ana Carolina Carvalho; Gabriel Casas; Huiting Dong; Gerardo Ferrara; Raffaele Filotico; Guillermo Gómez; Allan Halpern; Gennaro Ilardi; Akira Ishiko; Gulsen Kandiloglu; Hiroshi Kawasaki; Ken Kobayashi; Hiroshi Koga; Ivanka Kovalyshyn; David Langford; Xin Liu; Ashfaq A Marghoob; Massimo Mascolo; Cesare Massone; Laura Mazzoni; Scott Menzies; Akane Minagawa; Loredana Nugnes; Fezal Ozdemir; Giovanni Pellacani; Stefania Seidenari; Katherine Siamas; Ignazio Stanganelli; William V Stoecker; Masaru Tanaka; Luc Thomas; Philipp Tschandl; Harald Kittler
Journal:  J Am Acad Dermatol       Date:  2011-10-06       Impact factor: 11.527

3.  Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000.

Authors:  Susan M Swetter; Jennifer C Boldrick; Sandy Y Jung; Barbara M Egbert; Jeff D Harvell
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

6.  Early melanoma detection: nonuniform dermoscopic features and growth.

Authors:  Chere R Lucas; Linda L Sanders; John C Murray; Sarah A Myers; Russell P Hall; James M Grichnik
Journal:  J Am Acad Dermatol       Date:  2003-05       Impact factor: 11.527

7.  Use of digital epiluminescence microscopy to help define the edge of lentigo maligna.

Authors:  June K Robinson
Journal:  Arch Dermatol       Date:  2004-09

8.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

9.  Tanning bed exposure increases the risk of malignant melanoma.

Authors:  William Ting; Kara Schultz; Natalie N Cac; Michael Peterson; Hobart W Walling
Journal:  Int J Dermatol       Date:  2007-12       Impact factor: 2.736

10.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

View more
  6 in total

1.  Real-time supervised detection of pink areas in dermoscopic images of melanoma: importance of color shades, texture and location.

Authors:  R Kaur; P P Albano; J G Cole; J Hagerty; R W LeAnder; R H Moss; W V Stoecker
Journal:  Skin Res Technol       Date:  2015-03-22       Impact factor: 2.365

2.  Patient concern as a predictor of cutaneous malignancy.

Authors:  W V Stoecker; R K Rader; H S Rabinovitz; M Oliviero; D A Calcara; J M Malters; R J Drugge; M L Bernard; L A Perry; A A Marghoob
Journal:  Br J Dermatol       Date:  2015-11-18       Impact factor: 9.302

3.  Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men.

Authors:  Andrew C Walls; Jiali Han; Tricia Li; Abrar A Qureshi
Journal:  Am J Epidemiol       Date:  2013-04-11       Impact factor: 4.897

4.  The pink rim sign: location of pink as an indicator of melanoma in dermoscopic images.

Authors:  Ryan K Rader; Katie S Payne; Uday Guntupalli; Harold S Rabinovitz; Maggie C Oliviero; Rhett J Drugge; Joseph J Malters; William V Stoecker
Journal:  J Skin Cancer       Date:  2014-02-03

5.  Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma.

Authors:  Hanwen Wang; Xiaoxia Xie; Junyou Zhu; Shaohai Qi; Julin Xie
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

6.  Suspected melanoma only when the lesion is greater than 6mm may harm patients.

Authors:  Renato Santos de Oliveira Filho; Daniel Arcuschin de Oliveira; Murilo Costa Souza; Mariane da Silva; Mireille Darc Cavalcanti Brandão
Journal:  Einstein (Sao Paulo)       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.